Modalis Therapeutics (TSE:4883) Other Long Term Assets : 円73.38 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics Other Long Term Assets?

Modalis Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was 円73.38 Mil.

Modalis Therapeutics's quarterly other long-term assets declined from Sep. 2023 (円74.18 Mil) to Dec. 2023 (円69.60 Mil) but then increased from Dec. 2023 (円69.60 Mil) to Mar. 2024 (円73.38 Mil).

Modalis Therapeutics's annual other long-term assets declined from Dec. 2021 (円73.31 Mil) to Dec. 2022 (円68.61 Mil) but then increased from Dec. 2022 (円68.61 Mil) to Dec. 2023 (円69.60 Mil).

Modalis Therapeutics Other Long Term Assets Historical Data

The historical data trend for Modalis Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics Other Long Term Assets Chart

Modalis Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

14.50

10.88

73.31

68.61

69.60

Modalis Therapeutics Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial														68.10	72.85	74.18	69.60	73.38

Modalis Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Modalis Therapeutics (TSE:4883) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026

Website

https://www.modalistx.com

Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics (TSE:4883) Headlines

No Headlines